There are 337 (276 public and 61 private) lifescience companies presenting starting Monday, 1/11 and running through Thursday, 1/14. Link: JPMHealthcareConference-Agenda1.7
Public company presentations are usually web-cast enabling non-participants to view presentations with breakout sessions immediately following their presentations. These web-casts will be available for 3 months after the conference: https://events.jpmorgan.com/ ; so click on the web-cast link (no need for a user name and password but will be prompted an email address). As related to current economic times, registration of attendees was limited by JP Morgan to a total of about 3,500 versus 6,000 in the past years.
Read more…
Advanced Cell Technology (ACTC.OB or ACT) filed an Investigational New Drug (IND) application on 11/18/09 to conduct a PI/II trial using hESCs to treat a genetic eye disease. Read more…
Referencing our previous 4 blogs; I thought I would back-up my posts with a few stem cell topic definitions (3 of 3 blogs); these were extrapolated from various websites and a sector report I have put together as well as excerpts from the International Society for Stem Cell Research.
Are some kinds of stem cells better than others?
Referencing our previous 3 blogs; I thought I would back-up my posts with a few stem cell topic definitions (2 of 3 blogs); these were extrapolated from various websites and a sector report I have put together as well as excerpts from the International Society for Stem Cell Research.
What is a stem cell line? Read more…
Referencing our previous 2 blogs; I thought I would back-up my posts with a few stem cell topic definitions (1 of 3 blogs); these were extrapolated from various websites and a sector report I have put together as well as excerpts from the International Society for Stem Cell Research.
What are stem cells?
Read more…
Stem cell technologies are anticipated to provide the stimulus for cellular repair or regeneration. This can be achieved in different ways: by administering stem cells, or specific cells that are derived from stem cells in the laboratory or by administering drugs that coax stem cells that are already present in tissues to more efficiently repair the involved tissue.
Read more…
Stem cells are the foundation cells for every organ, tissue and cell in the body and can be used to generate healthy and functioning specialized cells, which can then replace diseased or dysfunctional cells. Stem cells can treat debilitating diseases like Alzheimer’s disease, cancer, Parkinson’s disease, type-1 diabetes, spinal cord injury, stroke, burns, heart disease, osteoarthritis and rheumatoid arthritis. Stem cells can serve as an alternative and renewable source for specialized cells. We believe that the stem cell companies have accumulated the requisite reproductive biology and tissue culture expertise to develop human therapeutics.
Read more…
Pharmaceutical researchers are now working on 861 medicines for cancer. Many are are in development involving innovative research on using existing medicines in new ways with many clinical trials proceeding. The medicines in development—all in either clinical trials or under FDA review including: 122 for lung cancer, the leading cause of cancer death in the United States:
Read more…
All agree that small-cap healthcare companies – if they are to survive – need access to capital. Referencing previous financing and structures posts: these events could be a sign of a broader market recovery as I-Banks ramp-up their capacity and capability in restructuring, advisory and underwriting. Large and small investment banks such as: Wells Fargo, Bank of America Merrill Lynch, Centerview Partners, Jefferies & Company, Morgan Joseph, Thomas Weisel Partners and Leerink Swann have hired bankers amid expectations of financing activity.
Read more…
I keep reiterating, research coverage is still the starting point of an investment decision.
Read more…
